Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.80 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.55 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.55 |
| ▸ | PARP1 | P09874 | 1/20 | 0.55 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.55 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6759145 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 | |
| SCHEMBL3160193 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 | |
| SCHEMBL3165188 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 | |
| SCHEMBL6753973 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 | |
| SCHEMBL3166862 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 | |
| SCHEMBL4157093 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 | |
| SCHEMBL1635316 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 | |
| SCHEMBL21074081 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 | |
| SCHEMBL21074131 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 | |
| SCHEMBL6755298 | 1.00 | POLB (0.80) | POLBDDAH1NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0428260-B1 | Metal surface treatment agents | SANWA LAB LTD (JP) | 2000-01-05 | — | — | EP | claimed |
| EP-0562187-B1 | Process for production of copper through-hole printed wiring boards | SANWA LAB LTD (JP) | 1996-01-10 | — | — | EP | claimed |
| US-5275694-A | Printed circuits with copper through holes, negative patterns, photoresists, lamination, dipping and etching | SANWA LABORATORY LTD. (JP) | 1994-01-04 | — | — | US | claimed |
| EP-0562187-A1 | Process for production of copper through-hole printed wiring boards | SANWA LABORATORY LTD. (JP) | 1993-09-29 | — | — | EP | claimed |
| US-5173130-A | Immersing copper or alloy to be soldered in an aqueous solution containing a 2-alkylbenzimidazole and an organic acid to form a corrosion and heat resistant protective coating | SHIKOKU CHEMICALS CORPORATION (JP) | 1992-12-22 | — | — | US | claimed |
| EP-0428260-A2 | Metal surface treatment agents | SANWA LABORATORY LTD. (JP) | 1991-05-22 | — | — | EP | claimed |
| US-20250215572-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | SHIKOKU CHEMICALS CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4506488-A1 | SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY | Shikoku Chemicals Corporation (JP) | 2025-02-12 | — | — | EP | disclosed |
| CN-118922584-A | Surface treating agent for copper or copper alloy | 四国化成工业株式会社 | 2024-11-08 | — | — | CN | disclosed |
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-05-30 | — | — | US | disclosed |
| EP-4347544-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | Dow Technology Investments LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| CN-117242047-A | Process for the vapor phase hydrogenation of aldehydes | 陶氏技术投资有限责任公司 | 2023-12-15 | — | — | CN | disclosed |
| WO-2023210058-A1 | INSULATED ELECTRIC WIRE, COIL USING SAME, AND METHOD FOR MANUFACTURING INSULATED ELECTRIC WIRE | 株式会社TOTOKU | 2023-11-02 | — | — | WO | disclosed |
| EP-0428383-A1 | Process for surface treatment of copper and copper alloy | SHIKOKU CHEMICALS CORPORATION (JP) | 1991-05-22 | — | — | EP | disclosed |
| US-4954434-A | COMPLEXING WITH ANTIBODIES | MOROZ CHAYA (IL) | 1990-09-04 | — | — | US | disclosed |
| US-4944768-A | IMPROVED WATER SOLUBILITY | CIBA-GEIGY CORPORATION (US) | 1990-07-31 | — | — | US | disclosed |
| US-4882270-A | Monoclonal antibodies to placental isoferritin for use in detecting oncofetal ferritin associated with breast cancer and Hodgkins disease | MOROZ CHAYA (IL) | 1989-11-21 | — | — | US | disclosed |
| EP-0251760-A2 | Rubber composition | Bridgestone Corporation (JP) | 1988-01-07 | — | — | EP | disclosed |
| US-4478907-A | Aqueous copolyester dispersions suited for the subbing of polyester film | AGFA-GEVAERT N.V. (BE) | 1984-10-23 | — | — | US | disclosed |
| EP-0029620-A1 | Aqueous copolyester dispersions suited for the subbing of polyester film, subbed polyester film and photographic materials containing a subbed polyester base | AGFA-GEVAERT N.V. (BE) | 1981-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | ADH1C, ADH5, ALDH2 | POLB 32/4885DDAH1 788/4885NPC1 4654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.